Industry Verticals »

All Categories

Insights »

About TMR »

Peripheral Vascular Devices Market

Peripheral Vascular Devices Market (Peripheral Vascular Stents, PTA Balloon Catheters, Guidewires, IVC Filters, Atherectomy, Chronic Total Occlusion, Embolic Protection Devices, Synthetic Surgical Grafts, Aortic Stents) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012-2018

Peripheral vascular disease (PVD) is narrowing of arteries outside the brain and heart. Risk factors for the growth of PVD include hypertension, obesity, diabetes and smoking. More than 5% of the population above the age of 50 years suffers from PVD. Insufficient blood flow and narrowing of arteries are the most common peripheral diseases caused due to plaque buildup. The global market for peripheral vascular devices was valued at USD 4,802.6 million in 2011, with an expected CAGR of 7.1% from 2012 to 2018. The North American region accounts for the largest market share. Asia-Pacific is the fastest growing market, on account of favorable demographic and economic conditions.

The major segments in the market include peripheral vascular stents, peripheral transluminal angioplasty balloon catheters, PTA guidewires, atherectomy devices, chronic total occlusion devices, aortic stents, synthetic surgical grafts, embolic protection devices and inferior vena cava filters. Embolic protection devices are the fastest growing segment in the total peripheral vascular devices market.

Growth of the global peripheral vascular devices market is fuelled by the rate of population growth globally and the high incidence of peripheral vascular diseases due to increasing aging population. Rising healthcare awareness and increasing disposable incomes are other important factors driving the growth of the market.

Key players such as Abbott Laboratories, Cordis Corporation and Boston Scientific Corporation dominate the market with their global presence. With the increasing aging population in developed economies such as North America and Europe, the demand for peripheral vascular devices would also increase. Asia-Pacific will record a high CAGR, due to the continuous increase in population as well as disposable incomes. Economic growth and technological advancements are primary factors stimulating the growth of peripheral vascular devices market in Asia-Pacific region. Global Peripheral Vascular Devices Market, by Product Types, 2011 (USD Million)

    1. Executive Summary

        1.1. Market Snapshot: Global Peripheral Vascular Devices Market (2011 & 2018

        1.2. Global Peripheral Vascular Devices Market, by Product Types, 2011 (USD Million)

    2. Preface

        2.1. Report description

        2.2. Market Segmentation

        2.3. Research Methodology

    3. Industry Analysis

        3.1. Introduction

        3.2. Market Drivers

            3.2.1. Rapidly increasing aging population

            3.2.2. Rising incidence rate of PVD

            3.2.3. Increasing demand for minimally invasive endovascular procedures

            3.2.4. Increase in specialists treating PVD

            3.2.5. Impact Analysis of Market Drivers

        3.3. Market Restraints

            3.3.1. Infections from peripheral vascular implantations

            3.3.2. Strict approval process from government bodies

            3.3.3. Impact Analysis of Market Restraints

        3.4. Market Opportunities

            3.4.1. Big opportunity in emerging economies with high unmet needs

        3.5. Porter’s Five Forces Analysis

            3.5.1. Bargaining power of buyers

            3.5.2. Bargaining power of suppliers

            3.5.3. Threat of new entrants

            3.5.4. Threat of substitutes

            3.5.5. Competitive rivalry

        3.6. Market Attractiveness Analysis

    4. Global Peripheral Vascular Devices Market, by Segments

        4.1. Overview

            4.1.1. Global Peripheral Vascular Devices Market, by Product Types, 2010-2018 (USD Million)

        4.2. Peripheral Vascular Stents

            4.2.1. Global Peripheral Vascular Stents Market, by Segments, 2010-2018 (USD Million)

        4.3. Peripheral Transluminal Angioplasty (PTA) Balloon Catheters

            4.3.1. Global Peripheral Transluminal Angioplasty Balloon Catheters Market, 2010-2018 (USD Million)

        4.4. PTA Guidewires

            4.4.1. Global PTA Guidewires Market, 2010-2018 (USD Million)

        4.5. Atherectomy Devices

            4.5.1. Global Atherectomy Devices Market, by Segments, 2010-2018 (USD Million)

        4.6. Chronic Total Occlusion (CTO) Devices

            4.6.1. Global Chronic Total Occlusion Devices Market, 2010-2018 (USD Million)

        4.7. Aortic Stents

            4.7.1. Global Aortic Stents Market, 2010-2018 (USD Million)

        4.8. Synthetic Surgical Grafts

            4.8.1. Global Synthetic Surgical Grafts Market, 2010-2018 (USD Million)

        4.9. Embolic Protection Devices

            4.9.1. Global Embolic Protection Devices Market, by Segments, 2010-2018 (USD Million)

        4.10. Inferior Vena Cava Filters

            4.10.1. Global Inferior Vena Cava Filters Market, by Segments, 2010-2018 (USD Million)

    5. Global Peripheral Vascular Devices Market, by Geography

        5.1. Overview

            5.1.1. Global Peripheral Vascular Devices Market, by Geography, 2010-2018 (USD Million)

        5.2. Comparative Analysis: Peripheral Vascular Devices Market, by Geography, 2011 & 2018 (Value %)

        5.3. North America

            5.3.1. North America Peripheral Vascular Devices Market, by Segments, 2010-2018 (USD Million)

                5.3.1.1. Peripheral vascular stents

                5.3.1.2. Peripheral transluminal angioplasty balloon catheters

                5.3.1.3. PTA guidewires

                5.3.1.4. Atherectomy devices

                5.3.1.5. Chronic total occlusion devices

                5.3.1.6. Aortic stents

                5.3.1.7. Synthetic surgical grafts

                5.3.1.8. Embolic protection devices

                5.3.1.9. Inferior vena cava filters

        5.4. Europe

            5.4.1. Europe Peripheral Vascular Devices Market, by Segments, 2010-2018 (USD Million)

                5.4.1.1. Peripheral vascular stents

                5.4.1.2. Peripheral transluminal angioplasty balloon catheters

                5.4.1.3. PTA guidewires

                5.4.1.4. Atherectomy devices

                5.4.1.5. Chronic total occlusion devices

                5.4.1.6. Aortic stents

                5.4.1.7. Synthetic surgical grafts

                5.4.1.8. Embolic protection devices

                5.4.1.9. Inferior vena cava filters

        5.5. Asia-Pacific

            5.5.1. Asia-Pacific Peripheral Vascular Devices Market, by Segments, 2010-2018 (USD Million)

                5.5.1.1. Peripheral vascular stents

                5.5.1.2. Peripheral transluminal angioplasty balloon catheters

                5.5.1.3. PTA guidewires

                5.5.1.4. Atherectomy devices

                5.5.1.5. Chronic total occlusion devices

                5.5.1.6. Aortic stents

                5.5.1.7. Synthetic surgical grafts

                5.5.1.8. Embolic protection devices

                5.5.1.9. Inferior vena cava filters

        5.6. RoW

            5.6.1. RoW Peripheral Vascular Devices Market, by Segments, 2010-2018 (USD Million)

                5.6.1.1. Peripheral vascular stents

                5.6.1.2. Peripheral transluminal angioplasty balloon catheters

                5.6.1.3. PTA guidewires

                5.6.1.4. Atherectomy devices

                5.6.1.5. Chronic total occlusion devices

                5.6.1.6. Aortic stents

                5.6.1.7. Synthetic surgical grafts

                5.6.1.8. Embolic protection devices

                5.6.1.9. Inferior vena cava filters

    6. Competitive Landscape

        6.1. Market Share Analysis, by Key Players (%)

    7. Recommendations

        7.1. Research and development initiatives

        7.2. Investing in emerging economies

        7.3. Mergers and acquisitions to expand the market presence

    8. Company Profiles

        8.1. Abbott Laboratories

            8.1.1. Company Overview

            8.1.2. Financial Overview

            8.1.3. Product portfolio

            8.1.4. Business Strategies

            8.1.5. Recent developments

        8.2. Angioscore Inc.

            8.2.1. Company overview

            8.2.2. Financial overview

            8.2.3. Product portfolio

            8.2.4. Business strategies

            8.2.5. Recent developments

        8.3. Boston Scientific Corporation

            8.3.1. Company overview

            8.3.2. Financial overview

            8.3.3. Product portfolio

            8.3.4. Business strategies

            8.3.5. Recent developments

        8.4. C.R.Bard, Inc.

            8.4.1. Company overview

            8.4.2. Financial overview

            8.4.3. Product portfolio

            8.4.4. Business strategies

        8.5. Cook Group Inc.

            8.5.1. Company overview

            8.5.2. Financial overview

            8.5.3. Product portfolio

            8.5.4. Business strategies

            8.5.5. Recent developments

        8.6. Cordis Corporation

            8.6.1. Company overview

            8.6.2. Financial overview

            8.6.3. Product portfolio

            8.6.4. Business strategies

            8.6.5. Recent developments

        8.7. Covidien PLC

            8.7.1. Company overview

            8.7.2. Financial overview

            8.7.3. Product portfolio

            8.7.4. Business strategies

            8.7.5. Recent developments

        8.8. Edward Lifesciences Corporation

            8.8.1. Company overview

            8.8.2. Financial overview

            8.8.3. Product portfolio

            8.8.4. Business strategies

            8.8.5. Recent developments

        8.9. Medtronic Inc.

            8.9.1. Company Overview

            8.9.2. Financial Overview

            8.9.3. Product Portfolio

            8.9.4. Business Strategies

            8.9.5. Recent Developments

        8.10. St. Jude Medical

            8.10.1. Company overview

            8.10.2. Financial overview

            8.10.3. Product portfolio

            8.10.4. Business strategies

            8.10.5. Recent developments

        8.11. Volcano Corporation

            8.11.1. Company overview

            8.11.2. Financial overview

            8.11.3. Product portfolio

            8.11.4. Business strategies

            8.11.5. Recent developments

    List of Tables

    TABLE 1: Market Snapshot: Global Peripheral Vascular Devices Market (2011 & 2018)

    TABLE 2: Impact Analysis of Market Drivers

    TABLE 3: Impact Analysis of Market Restraints

    TABLE 4: Global Peripheral Vascular Devices Market, by Product Types, 2010-2018 (USD Million)

    TABLE 5: Global Peripheral Vascular Stents Market, by Segments, 2010-2018 (USD Million)

    TABLE 6: Global Atherectomy Devices Market, by Segments, 2010-2018 (USD Million)

    TABLE 7: Global Embolic Protection Devices Market, by Segments, 2010-2018 (USD Million)

    TABLE 8: Global Inferior Vena Cava Filters Market, by Segments, 2010-2018 (USD Million)

    TABLE 9: Global Peripheral Vascular Devices Market, by Geography, 2010-2018 (USD Million)

    TABLE 10: North America Peripheral Vascular Devices Market, by Segments, 2010-2018 (USD Million)

    TABLE 11: Europe Peripheral Vascular Devices Market, by Segments, 2010-2018 (USD Million)

    TABLE 12: Asia-Pacific Peripheral Vascular Devices Market, by Segments, 2010-2018 (USD Million)

    TABLE 13: RoW Peripheral Vascular Devices Market, by Segments, 2010-2018 (USD Million)

    List of Figures

    FIG. 1: Global Peripheral Vascular Devices Market, by Product Types, 2011 (USD Million)

    FIG. 2: Peripheral Vascular Devices: Market Segmentation

    FIG. 3: Porter’s Five Forces Analysis: Global Peripheral Vascular Devices Market

    FIG. 4: Market Attractiveness Analysis: Global Peripheral Vascular Devices Market, by Geography

    FIG. 5: Global Peripheral Transluminal Angioplasty Balloon Catheters Market, 2010-2018 (USD Million)

    FIG. 6: Global PTA Guidewires Market, 2010-2018 (USD Million)

    FIG. 7: Global Chronic Total Occlusion Devices Market, 2010-2018 (USD Million)

    FIG. 8: Global Aortic Stents Market, 2010-2018 (USD Million)

    FIG. 9: Global Synthetic Surgical Grafts Market, 2010-2018 (USD Million)

    FIG. 10: Comparative Analysis: Peripheral Vascular Devices Market, by Geography, 2011 & 2018 (Value %)

    FIG. 11: Peripheral Vascular Devices: Market Share, by Key Players, 2012 (%)

    FIG. 13: Net Sales: Boston Scientific Corporation, 2010-2012 (USD Billion)

    FIG. 14: Net Sales: C.R.Bard, Inc., 2010-2012 (USD Billion)

    FIG. 15: Net Sales: Covidien Plc, 2010-2012 (USD Billion)

    FIG. 16: Net Sales: Edward Lifesciences Corporation, 2010-2012 (USD Billion)

    FIG. 17: Net Sales: Medtronic Inc., 2010-2012 (USD Billion)

    FIG. 18: Net Sales: St. Jude Medical, Inc., 2010-2012 (USD Billion)

    FIG. 19: Net Sales: Volcano Corporation, 2010-2012 (USD Million)

Copyright © Transparency Market Research, Inc. All Rights reserved

Peripheral Vascular Devices Market

Schedule a Call